{"bill":{"bill_id":1377265,"change_hash":"7c6946f5647165f6e52b05b5858467da","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/HB8139\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/8139\/all-info","completed":0,"status":1,"status_date":"2020-09-01","progress":[{"date":"2020-09-01","event":1},{"date":"2020-09-01","event":9}],"state":"US","state_id":52,"bill_number":"HB8139","bill_type":"B","bill_type_id":"1","body":"H","body_id":114,"current_body":"H","current_body_id":114,"title":"SUPPLIES Act of 2020 Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020","description":"Excludes certain short-dated drugs from rebate calculations under the Medicaid Drug Rebate Program during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). Specifically, the bill excludes from such calculations direct sales of drugs that (1) have a shelf life of one year or more and expire one year after the date of sale, or (2) have a shelf life of less than one year and expire after the same number of days as the shelf life following the date of sale.","pending_committee_id":2302,"committee":{"committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"},"referrals":[{"date":"2020-09-01","committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"}],"history":[{"date":"2020-09-01","action":"Introduced in House","chamber":"H","chamber_id":114,"importance":0},{"date":"2020-09-01","action":"Referred to the House Committee on Energy and Commerce.","chamber":"H","chamber_id":114,"importance":1}],"sponsors":[{"people_id":9209,"person_hash":"nnqnietk","party_id":"2","state_id":52,"party":"R","role_id":1,"role":"Rep","name":"Gus Bilirakis","first_name":"Gus","middle_name":"M.","last_name":"Bilirakis","suffix":"","nickname":"","district":"HD-FL-12","ftm_eid":12998704,"votesmart_id":17318,"opensecrets_id":"N00027462","knowwho_pid":193559,"ballotpedia":"Gus_Bilirakis","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":18332,"person_hash":"fizx4b9o","party_id":"1","state_id":52,"party":"D","role_id":1,"role":"Rep","name":"Darren Soto","first_name":"Darren","middle_name":"","last_name":"Soto","suffix":"","nickname":"","district":"HD-FL-9","ftm_eid":198924,"votesmart_id":67618,"opensecrets_id":"N00037422","knowwho_pid":255376,"ballotpedia":"Darren_Soto","sponsor_type_id":2,"sponsor_order":2,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13783,"subject_name":"Cardiovascular and respiratory health"},{"subject_id":13308,"subject_name":"Emergency medical services and trauma care"},{"subject_id":13216,"subject_name":"Home and outpatient care"},{"subject_id":13706,"subject_name":"Infectious and parasitic diseases"},{"subject_id":13493,"subject_name":"Inflation and prices"},{"subject_id":13239,"subject_name":"Medicaid"},{"subject_id":13490,"subject_name":"Prescription drugs"}],"texts":[{"doc_id":2207736,"date":"2020-09-08","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/HB8139\/id\/2207736","state_link":"https:\/\/www.congress.gov\/116\/bills\/hr8139\/BILLS-116hr8139ih.pdf","text_size":300029,"text_hash":"a3e580dcbdb7f305b8f7cd73022556a8"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}